Editorial & Fact-Checking Policy

Effective Date: November 18, 2026
Last Medically Reviewed: November 2026

1. Our Clinical & Editorial Mission

At 4mg.in, our mission is to provide accurate, accessible, and evidence-based health, pharmacological, and financial information. In a digital landscape often clouded by misinformation and unverified health claims, 4mg.in is committed to upholding the highest standards of clinical accuracy, journalistic integrity, and editorial transparency.

Every health monograph, clinical drug guide, nutrition breakdown, and financial calculator published on 4mg.in is designed to empower individuals with reliable, understandable, and actionable information to support meaningful conversations with their qualified healthcare providers or financial advisors.

2. Evidence Standards & Primary Medical Sources

4mg.in enforces rigorous evidence standards. We prioritize primary clinical literature, peer-reviewed medical research, and official public health guidelines. Our editorial team relies strictly on recognized regulatory authorities, academic institutions, and biomedical databases, including:

  • Peer-Reviewed Biomedical Literature: PubMed / MEDLINE, The Lancet, The New England Journal of Medicine (NEJM), BMJ, and The Cochrane Database of Systematic Reviews.
  • Regulatory Authorities: Central Drugs Standard Control Organisation (CDSCO – India), United States Food and Drug Administration (US FDA), European Medicines Agency (EMA), and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
  • Public Health Organizations: World Health Organization (WHO), Indian Council of Medical Research (ICMR), Centers for Disease Control and Prevention (CDC), and National Institutes of Health (NIH).
  • Clinical Pharmacopeias: Indian Pharmacopoeia (IP), British Pharmacopoeia (BP), and United States Pharmacopeia (USP).

We do not cite non-peer-reviewed blogs, sensationalist media, commercial product marketing materials, or unverified secondary aggregators for clinical claims.

3. Two-Tier Clinical Review & Fact-Checking Process

To ensure total reliability, our content undergoes a structured two-tier editorial and medical review pipeline before publication:

  1. Clinical Research & Drafting: Articles are authored by specialized medical writers and health researchers who synthesize evidence directly from primary clinical monographs, pharmacological data sheets, and therapeutic guidelines.
  2. Independent Medical Review: Before publication, all clinical drug monographs, symptom guides, and therapeutic articles are independently reviewed and fact-checked by qualified medical professionals—including licensed physicians (MD/MBBS) and clinical pharmacists (PharmD). Reviewers verify dosage safety, contraindications, drug interactions, black box warnings, and patient guidance.
  3. Clear Attribution: Articles that have completed clinical verification proudly display our Medically Reviewed & Fact-Checked badge, citing the supervising clinician and review date.

4. Author Credentials & Editorial Leadership

Editorial oversight of 4mg.in is led by Dr. Lisa Matthews, PharmD, Chief Clinical Editor, alongside a network of contributing medical researchers and financial analysts. Every author on 4mg.in possesses demonstrated subject-matter expertise in their domain. Author profiles detail their educational background, professional credentials, and clinical or financial experience.

5. Content Maintenance, Audits & Updates Protocol

Clinical science and financial regulations evolve continuously. To maintain ongoing accuracy, 4mg.in maintains a scheduled review cycle:

  • Quarterly Pharmacological Audits: Clinical drug monographs are re-evaluated every 90 to 180 days to reflect new CDSCO / FDA safety advisories, updated drug-drug interactions, or newly approved generic formulations.
  • Immediate Safety Bulletins: If a regulatory agency issues an urgent drug recall or black box warning revision, our editorial team updates the corresponding monographs within 24 hours.
  • Timestamp Transparency: Every article displays both the original publication date and the most recent clinical review or update timestamp.

6. Commercial Independence & Advertising Separation

Editorial integrity is our paramount commitment. 4mg.in maintains strict separation between editorial content and any commercial relationships:

  • Zero Pharmaceutical Sponsorship: We do not accept funding, sponsorship, or editorial direction from pharmaceutical manufacturers, supplement distributors, or financial institutions to promote specific drugs or products.
  • Objective Brand Listings: Commercial brand names listed in our drug monographs (e.g., Crocin, Dolo 650, Calpol) are presented solely for educational identification and consumer safety, with zero endorsement or compensation.
  • Clear Advertising Boundaries: Any sponsored or display advertisements on 4mg.in are strictly partitioned from clinical text and clearly labeled. Advertisers have zero influence over clinical evaluations or editorial ratings.

7. Corrections & Public Feedback

We are committed to prompt, transparent corrections whenever factual or typographical errors occur. If you identify a statement, dosage, or reference that requires clarification or correction, we welcome your feedback. Please contact our medical editorial desk directly:

Editorial & Clinical Inquiries: [email protected]
General Inquiries: About 4mg.in | Medical Disclaimer